Sms Pharmaceuticals Ltd vs Trident Lifeline Ltd Stock Comparison
Sms Pharmaceuticals Ltd vs Trident Lifeline Ltd Stock Comparison
Last Updated on: May 03, 2026
Key Highlights
The Latest Trading Price of SMS Pharmaceuticals Ltd is ₹ 404.55 as of 30 Apr 15:30
. The P/E Ratio of SMS Pharmaceuticals Ltd changed from 16.8 on March 2021 to 27.3 on March 2025 . This represents a CAGR of 10.20% over 5 yearsThe P/E Ratio of Trident Lifeline Ltd changed from 30.4 on March 2023 to 25.1 on March 2025 . This represents a CAGR of -6.19% over 3 years The Market Cap of SMS Pharmaceuticals Ltd changed from ₹ 1053 crore on March 2021 to ₹ 1885 crore on March 2025 . This represents a CAGR of 12.36% over 5 yearsThe Market Cap of Trident Lifeline Ltd changed from ₹ 182.95 crore on March 2023 to ₹ 295.53 crore on March 2025 . This represents a CAGR of 17.33% over 3 years The revenue of SMS Pharmaceuticals Ltd for the Dec '25 is ₹ 214.2 crore as compare to the Sep '25 revenue of ₹ 243.86 crore. This represent the decline of -12.16% The revenue of Trident Lifeline Ltd for the Dec '25 is ₹ 30.34 crore as compare to the Sep '25 revenue of ₹ 33.01 crore. This represent the decline of -8.09% The ebitda of SMS Pharmaceuticals Ltd for the Dec '25 is ₹ 47.4 crore as compare to the Sep '25 ebitda of ₹ 49.8 crore. This represent the decline of -4.82% The ebitda of Trident Lifeline Ltd for the Dec '25 is ₹ 9.72 crore as compare to the Sep '25 ebitda of ₹ 8.53 crore. This represent the growth of 13.95% The net profit of SMS Pharmaceuticals Ltd changed from ₹ 16.37 crore to ₹ 23.19 crore over 7 quarters. This represents a CAGR of 22.02%
The net profit of Trident Lifeline Ltd changed from ₹ 1.6 crore to ₹ 4.65 crore over 7 quarters. This represents a CAGR of 83.98%
The Dividend Payout of SMS Pharmaceuticals Ltd changed from 4.17 % on March 2021 to 5.19 % on March 2025 . This represents a CAGR of 4.47% over 5 yearsThe Dividend Payout of Trident Lifeline Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Limited was incorporated in December, 1987.
The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh.
During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities.
During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24.
During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s.
VKT Pharma Private Limited.
About Trident Lifeline Ltd
Trident Lifeline Limited was originally incorporated as Private Limited Company as 'Trident Lifeline Private Limited' on January 09, 2014.
Subsequently, Company converted into a Public Limited and the name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022.
The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
It is also engaged in distribution of pharmaceutical products through third party distribution network.
Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license.
It operate in India as well as African, Latin American and East Indian Countries.
FAQs for the comparison of SMS Pharmaceuticals Ltd and Trident Lifeline Ltd
Which company has a larger market capitalization, SMS Pharmaceuticals Ltd or Trident Lifeline Ltd?
Market cap of SMS Pharmaceuticals Ltd is 3,788 Cr while Market cap of Trident Lifeline Ltd is 298 Cr
What are the key factors driving the stock performance of SMS Pharmaceuticals Ltd and Trident Lifeline Ltd?
The stock performance of SMS Pharmaceuticals Ltd and Trident Lifeline Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for SMS Pharmaceuticals Ltd and Trident Lifeline Ltd?
As of May 3, 2026, the SMS Pharmaceuticals Ltd stock price is INR ₹404.55. On the other hand, Trident Lifeline Ltd stock price is INR ₹250.05.
How do dividend payouts of SMS Pharmaceuticals Ltd and Trident Lifeline Ltd compare?
To compare the dividend payouts of SMS Pharmaceuticals Ltd and Trident Lifeline Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.